Tweets 1hEPGL Med ?@EPGLMed
Post# of 98052
Tweets
EPGL Med ?Receiving dozens of inquiries from physicians around the world at present. If you are a doctor, please seehttp://www.ncbi.nlm.nih.gov/pubmed/20030744
In 2013, MPDD enters the markets for treatment of back pain, neck pain, fibromyalgia, migraine, sports medicine and rehabilitation.
MPDD to offer physicians and Medicare a desperately needed diagnostic tool for superior diagnosis and treatment of chronic muscle pain.
MPDD device to offer a better diagnostic tool to the estimated $90 billion annual back pain treatment market in the United States.
The MPDD greatly increases the precision of the diagnosis of chronic and acute muscular pain, giving all physicians a powerful new tool.
The MPDD allows for the diagnosis of muscles pain origination in a dynamic, natural, state (as opposed to static).
Announcements to shareholders next week via PR national release: Future EPGL devices planned, MPDD release, New staff.
Chronic pain can originate several inches away from where it is perceived. MPDD accurately identifies the exact location for physicians...
We have another rising star doctor from NYU joining our team. Official announcement next week.
